Biohaven Pharmaceutical Holding Co Ltd (BHVN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE

Key Metrics

• Price: $11.16
• Market Cap: $1.53B
• EPS: $-7.52
• 52-Week High: $37.36
• 52-Week Low: $7.48

Market Sentiment

Biohaven Pharmaceutical Holding Co Ltd currently has a Neutral sentiment score of -0.12.

About Biohaven Pharmaceutical Holding Co Ltd

Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical innovator headquartered in New Haven, Connecticut, specializing in the development of transformative therapies for neurological diseases and rare disorders. The company harnesses its advanced research and development capabilities to deliver promising product candidates that aim to address significant unmet medical needs in the U.S. market. With a strong emphasis on scientific rigor and a commitment to patient-centric solution...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Biohaven Pharmaceutical Holding Co Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BHVN pay dividends?

Biohaven Pharmaceutical Holding Co Ltd (BHVN) does not currently pay a regular dividend.

What is BHVN's market cap?

Biohaven Pharmaceutical Holding Co Ltd (BHVN) has a market capitalization of $1.53B with a current stock price of $11.16.